Top View
- Repurposing the Aldose Reductase Inhibitor and Diabetic Neuropathy Drug Epalrestat for the Congenital Disorder of Glycosylation PMM2-CDG Sangeetha Iyer1, Feba S
- The Fate of Aldose Reductase Inhibition and Sorbitol Dehydrogenase Activation
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- United States Patent (19) 11 Patent Number: 6,166,043 Ikeda Et Al
- REVIEW ON: DIABETES MELLITUS 1 1 2 Pritee S
- Aldose Reductase Inhibitor Fidarestat Counteracts Diabetes-Associated Cataract Formation, Retinal Oxidative- Nitrosative Stress, Glial Activation, and Apoptosis
- Galactose Cataract Prevention with Sorbinil, an Aldose Reductase Inhibitor: a Light Microscopic Study
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- In-Silico Analysis of Natural Products That Modulates Enzymes of Diabetic Target
- Aldose Reductase Inhibitors As Potential Therapeutic Drugs of Diabetic Complications
- Diabetes Mellitus, Its Complications and Management
- Protective Effects of Dietary Chamomile Tea on Diabetic Complications
- Pharmaabkommen A1 E
- Customs Tariff - Schedule Xxi - 1
- Aldose Reductase
- (12) United States Patent (10) Patent No.: US 6,337,327 B1 Tuffin Et Al
- Diabetes Mellitus: Insights from Epidemiology, Biochemistry, Risk Factors, Diagnosis, Complications and Comprehensive Management
- The Polyol Pathway and Glucose 6-Phosphate in Human Endothelial Cells Cultured in High Glucose Concentrations
- Inhibitor Selectivity Between Aldo–Keto Reductase Superfamily Members AKR1B10 and AKR1B1: Role of Trp112 (Trp111)
- A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
- Epalrestat Increases Intracellular Glutathione Levels in Schwann Cells Through Transcription Regulation$
- Intranasal Insulin for Treatment of Diabetic Polyneuropathy
- Serving Individuals with Diabetes Who Are Blind Or Visually Impaired: a Resource Guide for Vocational Rehabilitation Counselors
- Stop Crying Over Spilled Milk, Thanks to Recent Reports Which Suggest
- Diabetic Retinopathy and Diabetic Macular Edema Pathophysiology, Screening, and Novel Therapies
- Pyrimidine As Aldose Reductase Differential Inhibitors
- Chronic Kidney Disease and Type 2 Diabetes
- (12) United States Patent (10) Patent No.: US 8,575,321 B2 Chen Et Al
- Ciglitazone-Induced Lenticular Opacities in Rats: in Vivo and Whole Lens Explant Culture Evaluation
- Schedule Clxxiii - European Union
- Evaluation of the Anti-Diabetic Activity of Some Common Herbs and Spices: Providing New Insights with Inverse Virtual Screening
- The Effect of an Aldose Reductase Inhibitor (Sorbinil) on the Level of Metabolites in Lenses of Diabetic Rats ANA-MARIA GONZALEZ, MILENA SOCHOR, and PATRICIA Mclean